Imegen-SARS-CoV-2

Detection of SARS-CoV-2 coronavirus in respiratory samples by detecting the N, S and ORF1ab genes and the endogenous human RNase P gene by real-time reverse transcription (rRT-PCR)

96 rxn

Reverse transcription in real time

IMG-356

Characteristics

  • Qualitative multiplexed assay that allows determining the presence of 3 specific SARS-CoV-2 targets and one endogenous human target by studying two multiplexed rRT-PCR reactions.
  • The endogenous human gene, RNase P, makes it possible to evaluate the quality of the sample.
  • Detection limit: 10 copies
  • Genomic inclusivity:In silicadesign based on 3,123 genomes (GISAID)
  • It complies with the quality requirements specified by ISO 13485 and ISO 14001 regarding the materials used in its manufacturing process.
  • For in vitrodiagnostic use.
  • Approved by the Instituto de Salud Carlos III (ISCiii)

Technology

Imegen SARS-CoV-2 is a real-time reverse transcription PCR test intended for the qualitative detection of RNA extracted from SARS-CoV-2 in nasal swab, nasopharyngeal swab, and oropharyngeal swab samples taken from the upper respiratory tract of individuals. suspects of COVID-19 by your medical specialist.

Technical specifications

  • Sample type: RNA purified from respiratory samples
  • Amount of sample required: 12 µL
  • Number of reactions per sample: 2
  • Number of targets: 4
  • Manual work time: 10 – 30 min
  • Duration of the rRT-PCR program: 1h 20 min
  • Supported Platforms: 7500 FAST Real-Time PCR System (ThermoFisher Scientific), StepOne Real-Time PCR System (ThermoFisher Scientific), CFX96 Touch Real-Time PCR System (BioRad), CFX96 Real-Time PCR System (BioRad), Light Cycler 480 PCR System (Roche)

Imegen-SARS-CoV-2

Fill in the form to request this kit.

Call us at +34 963 212 340

Or write to us at info@healthincode.com